4 11, 2015

Argentina could save U$11M per year buying generic version of Truvada®

2015-11-04T20:01:06-03:00miércoles, 4 noviembre, 2015|Access to Medicines, Advocacy, Health Safeguards, Intellectual Property, Patent opposition|

The Argentine Community of People Living with HIV requested the rejection of a patent for an essential HIV/AIDS medicine. If the Argentine Patent Office does grant the this request, Argentina could produce generic versions at a lower cost representing a potential saving of over US$11 million. Argentina April 13th, 2015.- The Grupo Efecto Positivo Foundation (FGEP) in collaboration with the Argentine

11 09, 2015

UNAIDS “4th 90”: Affordability of Medicines

2015-11-04T16:38:17-03:00viernes, 11 septiembre, 2015|909090 Strategy, Access to Medicines, Argentina, Medicines, Ministry of Health, Public Health, UNAIDS|

UNAIDS has seen Argentina´s proposal to add a 4th “90” to its 909090 Strategy as a model to be implemented worldwide Buenos aires, September 2015 – UNAIDS´s Executive Director, Michel Sidibé, visit Argentina and Chile in his first time visit to Latin American region as part of a global tour to promote 90-90-90 strategy which

Ir a Arriba